Cyclosporin A inhibits the replication of diverse coronaviruses.
J Gen Virol
; 92(Pt 11): 2542-2548, 2011 Nov.
Article
en En
| MEDLINE
| ID: mdl-21752960
Low micromolar, non-cytotoxic concentrations of cyclosporin A (CsA) strongly affected the replication of severe acute respiratory syndrome coronavirus (SARS-CoV), human coronavirus 229E and mouse hepatitis virus in cell culture, as was evident from the strong inhibition of GFP reporter gene expression and a reduction of up to 4 logs in progeny titres. Upon high-multiplicity infection, CsA treatment rendered SARS-CoV RNA and protein synthesis almost undetectable, suggesting an early block in replication. siRNA-mediated knockdown of the expression of the prominent CsA targets cyclophilin A and B did not affect SARS-CoV replication, suggesting either that these specific cyclophilin family members are dispensable or that the reduced expression levels suffice to support replication.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Antivirales
/
Ciclosporina
/
Virus de la Hepatitis Murina
/
Coronavirus Humano 229E
/
Coronavirus Relacionado al Síndrome Respiratorio Agudo Severo
Límite:
Animals
/
Humans
Idioma:
En
Revista:
J Gen Virol
Año:
2011
Tipo del documento:
Article
País de afiliación:
Países Bajos
Pais de publicación:
Reino Unido